Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss (NCT07446998)
PLATEAU: Phase 2b Proof-of-Concept Study to Evaluate the Effect on Total Body Weight, Physical Function and Safety of Enobosarm in Patients Treated With Semaglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, for Weight Reduction
🩺 Plain-English Summary (8th-Grade Level)
The primary objective of this study is to assess the effect of enobosarm on total body weight
Who can join: Review the eligibility criteria below.
Location: DM Clinical Research - Phoenix — Phoenix, Arizona
Age range: 65 Years to 100 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (14 Sites)
- DM Clinical Research - Phoenix — Phoenix, Arizona
- DM Clinical Research - MIA — Doral, Florida
- Universal Axon Clinical Research (Rovia - UACR) — Doral, Florida
- Paramo Health — Miami, Florida
- IMIC Research a Rovia Clinical Research Company — Miami, Florida
- Paramo Health — Miami, Florida
- UD Research — Atlanta, Georgia
- Pennington Biomedical Research Center — Baton Rouge, Louisiana
- Centennial Medical Group (CMG) — Columbia, Maryland
- SKY Integrative Medical Center — Ridgeland, Mississippi
- ALSA Research — New York, New York
- Coastal Research Institute, LLC — Fayetteville, North Carolina
- DM Clinical - Dallas — Irving, Texas
- DM Clinical - Seattle — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (800) 606-9382
Email: veruclinicaltrials@verupharma.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity & Overweight
- Dietary Reversal of the Reprometabolic Syndrome — Aurora, Colorado
- Ultra-processed Food Consumption and Health Pilot Study — Baton Rouge, Louisiana
- Personalizing Financial Incentives — Salt Lake City, Utah
- A Study Comparing Continuous Glucose Monitoring Augmented Nutritional Counseling and Standard of Care Treatment Strategies in a Three-Month Nutrition Intervention — Gainesville, Florida
- Augmenting Primary Care-Based Obesity Management With the Nutu™ Digital Health Platform — Birmingham, Alabama
- Effect Of Whole or Skimmed Milk Greek Yogurt on Integrated Muscle Protein Synthesis, Glucose Homeostasis, and Cognition in Post-Menopausal Women — Little Rock, Arkansas
Explore by condition: All Obesity & Overweight clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.